About Shannon Boye
Form D filings for Atsena Therapeutics from 2020 to 2023 list Shannon Boye as director.
Shannon Boye first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Shannon Boye in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shannon Boye works with at each company, as listed on that company's latest Form D.
Atsena Therapeutics, Inc. · Form D, Oct 2, 2023
MD
Michael Dial
Director
JW
Jennifer Wellman
Director
JG
Jacqueline Grant
Director
PR
Patrick Ritschel
Chief Executive Officer and director
EL
Elizabeth Leiderman
Executive officer
JH
James Healy
Director
CI
Christina Isacson
Director